Clinical trial
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Origin
NCT01182285 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Origin
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 24, 2010
- Completion date
- April 28, 2016
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid neoplasm